Niguarda Hospital provides care in all clinical specialties, delivered through 74 Clinical Units, arranged in 11 clinical departments. Every year Niguarda offers over 3.000.000 ambulatory visits and over 50.000 admissions. Among its clinical units, Niguarda includes 26 units which are reference point in Italy for their recognized specialties: cell factory, anti-poison center, regional emergency center (city emergency plan headquarter), trauma burn center, equestrian rehabilitation center, rare diseases unit (over 100 treated diseases), surgery. Besides, it has the MAPP Paolo Pini Art Museum, recognized as civic museum. Innovation to support clinical care, hi-tech equipment and a full multidisciplinary approach are the main characters of this unique example of public hospital.

Niguarda is at the forefront of research with trials testing new therapies supported by international cooperation activities. Particular attention is also paid to non-sponsored research with high quality investigator driven studies. In recent years a positive trend in clinical trial has been observed, especially in neuroscience, diabetology, pain therapy, gene therapy, cardiovascular diseases, haematology, oncology, resulting in an improved average impact factor. Although Niguarda is a public hospital dedicated to care, clinical research and knowledge sharing are fully integrated in the hospital strategy. Presence of professional skills, technological competences, certified laboratories and high complexity patient cohorts make Niguarda a unique and interesting partner for future cooperations.
It offers concrete opportunities to Pharma and Biotech Companies that are looking for a reliable and expert clinical/scientific partner.

Niguarda is one of the biggest general hospital in Italy, national and international reference center for many diseases and therapeutic areas. It offers concrete opportunities to Pharma and Biotech Companies which are looking for a reliable and expert clinical/scientific partner. Three the key success factors in supporting research:

high level of professional skills of hospital staff in many different specialties
high potential in terms of patient recruitment (reference institution, both at a regional and national level, in almost every medical and surgical specialty) and high technological profile

The attitude to a real multidisciplinary approach offered to researcher constitutes Niguarda as a unique “one stop shop” for research and development.

The main strength point is the high volume of diagnostic/therapeutic activities and patient cohorts as well; it allows an optimal integration between research and patient care, defining Niguarda as one of the best possible clinical sites for translational research.